急诊就诊社区获得性肺炎的年龄与性别差异:一项回顾性队列研究
该回顾性队列研究纳入2017年1月1日至2018年12月31日期间在一家瑞士急诊科收治的467例影像学确诊CAP患者,其中女性211例(45%),≥65岁317例(68%)。主要目的是评估男 vs 女及>65岁 vs <65岁患者在临床表现和影像学表现上的差异。结果显示老年患者胸痛、发热、寒战、咳嗽、头痛和肌痛报告率均显著低于年轻患者,85%的无症状患者为≥65岁;女性PSI较低,男性痰液更常见;老年患者粗病死率更高(14% vs 3%,OR 4.67;95%CI 1.81-12.05),男女病死率相似(11% vs 10%;OR 1.22;95%CI 0.67-2.23)。结论认为年龄或性别均不是CAP病死率的预测因素。
要点
- ≥65岁CAP患者胸痛(13% vs 27%)、发热(39% vs 53%)、寒战(6% vs 20%)、咳嗽(44% vs 57%)、头痛(5% vs 15%)、肌痛(5% vs 19%)报告率均低于<65岁患者。
- 85%的无症状CAP患者年龄≥65岁,老年患者可能因症状不典型而被延误识别。
- 老年患者粗病死率14% vs 年轻患者3%(OR 4.67;95%CI 1.81-12.05)。
- 男女病死率相似(11% vs 10%;OR 1.22;95%CI 0.67-2.23),年龄或性别均不是CAP病死率的预测因素。
- 女性PSI较低[95(SD 31)vs 104(SD 31);95%CI -14.44至2.35],男性痰液更常见(32% vs 22%)。
适用人群与场景
- 2017年1月1日至2018年12月31日期间在一家瑞士急诊科收治的影像学确诊CAP患者,共467例;女性211例(45%),≥65岁317例(68%),其中女性145例(46%)。
研究设计与关键结果
- 回顾性队列研究,纳入一家瑞士急诊科467例影像学确诊CAP患者,比较男 vs 女及>65岁 vs <65岁患者的临床表现、影像学表现和结局。
- 老年患者较年轻患者更少报告胸痛(13% vs 27%;效应量14%;95%CI 0.07-0.23)、发热(39% vs 53%;效应量14%;95%CI 0.05-0.24)、寒战(6% vs 20%;效应量14%;95%CI 0.08-0.0.214,原文如此)、咳嗽(44% vs 57%;效应量13%;95%CI 0.03-0.22)、头痛(5% vs 15%;效应量10%;95%CI 0.04-0.17)和肌痛(5% vs 19%;效应量14%;95%CI 0.07-0.21)。
- 85%的无症状患者年龄≥65岁。
- 女性PSI较低[95(SD 31)vs 104(SD 31);95%CI -14.44至2.35]。
- 男性痰液更常见(32% vs 22%;效应量10%;95%CI -0.18至-0.02)。
- 老年患者粗病死率更高[14% vs 3%;OR 4.67;95%CI 1.81-12.05],男女病死率相似(11% vs 10%;OR 1.22;95%CI 0.67-2.23)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对≥65岁急诊CAP患者,不应因缺乏胸痛、发热、寒战、咳嗽、头痛或肌痛等典型症状而降低对CAP的怀疑。
- 原文结论指出,年龄或性别均不是CAP病死率的预测因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND IMPORTANCE: Because of its associated high morbidity and mortality, early identification and treatment of community-acquired pneumonia (CAP) are essential.
OBJECTIVES: To investigate age- and sex-related differences in clinical symptoms, radiologic findings and outcomes in patients presenting to the emergency department (ED) with CAP.
DESIGN: Retrospective cohort study.
SETTING AND PARTICIPANTS: Patients admitted to one Swiss ED with radiologically confirmed CAP between 1 January 2017 and 31 December 2018.
OUTCOME MEASURES AND ANALYSIS: Primary aim was to evaluate differences in clinical and radiologic presentation of men vs. women and patients >65 years vs. <65 years with CAP. Secondary outcomes were age- and sex-related differences in terms of Pneumonia Severity Index (PSI) risk class, need for ICU referral, mechanical ventilation, in-hospital mortality, 30-day readmission and 180-day pneumonia recurrence.
MAIN RESULTS: In total 467 patients with CAP were included. 211 were women (45%). 317 were ≥65 years (68%), of which 145 were women (46%). Older patients less commonly reported chest pain (13 vs. 27%; effect size 14%; 95% CI, 0.07-0.23), fever (39 vs. 53%, effect size 14%; 95% CI, 0.05-0.24), chills (6 vs. 20%; effect size 14%; 95% CI, 0.08-0.0.214), cough (44 vs. 57%; effect size 13%; 95% CI, 0.03-0.22), headache (5 vs. 15%, effect size 10%, 95% CI, 0.04-0.17) and myalgias (5 vs. 19%; effect size 14%; 95% CI, 0.07-0.21). However, 85% of patients with no symptoms were ≥65 years. PSI was lower in women [95 (SD 31) vs. 104 (SD 31); 95% CI, -14.44 to 2.35] and sputum was more common in men (32 vs. 22%; effect size 10%; 95% CI, -0.18 to -0.02). Raw mortality was higher in elderly patients [14 vs. 3%; odds ratio (OR), 4.67; 95% CI, 1.81-12.05], whereas it was similar in men and women (11 vs. 10%; OR, 1.22; 95% CI, 0.67-2.23).
CONCLUSION: Patients, less than 65 years with CAP presenting to the ED had significantly more typical symptoms such as chest pain, fever, chills, cough, headache and myalgias than those being above 65 years. No relevant differences between men and women were found in clinical presentation, except for PSI on admission, and radiologic findings and neither age nor sex was a predictor for mortality in CAP.
参考来源
- Ravioli S, Germann C, Gygli R, et al. Age- and sex-related differences in community-acquired pneumonia at presentation to the emergency department: a retrospective cohort study. Eur J Emerg Med. 2022. PMID: 35728060. doi:10.1097/MEJ.0000000000000933
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。